Cargando…
Superenhancers as master gene regulators and novel therapeutic targets in brain tumors
Transcriptional deregulation, a cancer cell hallmark, is driven by epigenetic abnormalities in the majority of brain tumors, including adult glioblastoma and pediatric brain tumors. Epigenetic abnormalities can activate epigenetic regulatory elements to regulate the expression of oncogenes. Superenh...
Autores principales: | Zhuang, Hai-Hui, Qu, Qiang, Teng, Xin-Qi, Dai, Ying-Huan, Qu, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9981748/ https://www.ncbi.nlm.nih.gov/pubmed/36720920 http://dx.doi.org/10.1038/s12276-023-00934-0 |
Ejemplares similares
-
The Emerging Role of Super-enhancers as Therapeutic Targets in The Digestive System Tumors
por: Li, Xiang-Ping, et al.
Publicado: (2023) -
Superenhancer–transcription factor regulatory network in malignant tumors
por: Liang, Yuan, et al.
Publicado: (2021) -
Superenhancers: Novel opportunities for nanowire optoelectronics
por: Khudiyev, Tural, et al.
Publicado: (2014) -
INO80 governs superenhancer-mediated oncogenic transcription and tumor growth in melanoma
por: Zhou, Bingying, et al.
Publicado: (2016) -
NaviSE: superenhancer navigator integrating epigenomics signal algebra
por: Ascensión, Alex M., et al.
Publicado: (2017)